ATE195415T1 - Kontinuierliche mikrodispersionen von fluorierten verbindungen zur verabreichung von pharmazeutischen stoffen - Google Patents
Kontinuierliche mikrodispersionen von fluorierten verbindungen zur verabreichung von pharmazeutischen stoffenInfo
- Publication number
- ATE195415T1 ATE195415T1 AT96918172T AT96918172T ATE195415T1 AT E195415 T1 ATE195415 T1 AT E195415T1 AT 96918172 T AT96918172 T AT 96918172T AT 96918172 T AT96918172 T AT 96918172T AT E195415 T1 ATE195415 T1 AT E195415T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical
- pharmaceutical composition
- microdispersions
- administration
- continuous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/482,176 US5667809A (en) | 1995-06-07 | 1995-06-07 | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents |
PCT/US1996/009081 WO1996040053A1 (en) | 1995-06-07 | 1996-06-05 | Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE195415T1 true ATE195415T1 (de) | 2000-09-15 |
Family
ID=23915021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96918172T ATE195415T1 (de) | 1995-06-07 | 1996-06-05 | Kontinuierliche mikrodispersionen von fluorierten verbindungen zur verabreichung von pharmazeutischen stoffen |
Country Status (18)
Country | Link |
---|---|
US (1) | US5667809A (de) |
EP (1) | EP0831770B1 (de) |
JP (1) | JPH11506783A (de) |
KR (1) | KR100454377B1 (de) |
CN (1) | CN1192135A (de) |
AT (1) | ATE195415T1 (de) |
AU (1) | AU721759B2 (de) |
CA (1) | CA2222081A1 (de) |
DE (1) | DE69609834T2 (de) |
DK (1) | DK0831770T3 (de) |
ES (1) | ES2150674T3 (de) |
GR (1) | GR3034657T3 (de) |
HU (1) | HUP9900872A2 (de) |
IL (1) | IL122241A0 (de) |
NO (1) | NO975320L (de) |
PL (1) | PL323829A1 (de) |
PT (1) | PT831770E (de) |
WO (1) | WO1996040053A1 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3211740B2 (ja) * | 1997-08-28 | 2001-09-25 | ダイキン工業株式会社 | 化粧料 |
US6433040B1 (en) * | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6410255B1 (en) * | 1999-05-05 | 2002-06-25 | Aurora Biosciences Corporation | Optical probes and assays |
KR100856353B1 (ko) | 1999-05-14 | 2008-09-04 | 니리어스 파마슈티컬즈, 인크. | 신규한 인터루킨-1 및 종양사멸인자-α의 조절인자들,상기 조절인자들의 합성 및 상기 조절인자들의 사용 방법 |
EP1259608B1 (de) | 2000-02-23 | 2009-08-12 | Life Technologies Corporation | Veränderte, fluoreszierende proteine |
PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
JP4395549B2 (ja) * | 2000-11-16 | 2010-01-13 | ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア | 薬物及び発酵生成物の発見のための海洋放線菌分類群 |
US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US7244703B2 (en) * | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
CA2461349C (en) | 2001-09-26 | 2011-11-29 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
EP1458360B1 (de) | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonale verabreichung von aminoglykosiden |
US7176232B2 (en) * | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
US7112581B2 (en) * | 2002-09-27 | 2006-09-26 | Nereus Pharmaceuticals, Inc. | Macrocyclic lactams |
GB0307403D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
CN1823070A (zh) * | 2003-06-20 | 2006-08-23 | 加利福尼亚大学董事会 | 盐孢菌酰胺及其使用方法 |
CN102151261A (zh) * | 2003-06-20 | 2011-08-17 | 尼瑞斯药品公司 | [3.2.0]杂环化合物及其类似物在癌症、炎症和感染性疾病治疗中的应用 |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
KR100978717B1 (ko) | 2003-12-08 | 2010-08-30 | 씨펙스 파마슈티칼스, 인코포레이티드 | 인슐린 치료를 위한 약제 조성물 및 방법 |
BRPI0506535A (pt) * | 2004-01-23 | 2007-02-27 | Nereus Pharmaceuticals Inc | pirroles bis-indole úteis como agentes anti-microbiais |
NZ550910A (en) * | 2004-04-30 | 2011-06-30 | Nereus Pharmaceuticals Inc | [3.2.0] Heterocyclic compounds and methods of using the same |
US7579371B2 (en) | 2004-04-30 | 2009-08-25 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
DK1830838T3 (da) | 2004-12-03 | 2013-01-21 | Dana Farber Cancer Inst Inc | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme |
DE102005009194B4 (de) * | 2005-03-01 | 2006-12-14 | Hpp-Hommel Pharmaceuticals Production Gmbh | Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid |
WO2007015757A2 (en) | 2005-07-21 | 2007-02-08 | Nereus Pharmaceuticals, Inc. | Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators |
US7319570B2 (en) | 2005-09-19 | 2008-01-15 | Seagate Technology Llc | Random vibration and shock compensator using a disturbance observer |
US7824698B2 (en) * | 2007-02-02 | 2010-11-02 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of Salinosporamide A |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US20090017167A1 (en) * | 2007-07-11 | 2009-01-15 | Herbalife International Inc. | Mixture and beverage made therefrom for protecting cellular hydration |
US8394816B2 (en) * | 2007-12-07 | 2013-03-12 | Irene Ghobrial | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
US7910616B2 (en) * | 2008-05-12 | 2011-03-22 | Nereus Pharmaceuticals, Inc. | Proteasome inhibitors |
EP2123256A1 (de) | 2008-05-19 | 2009-11-25 | Ruhr-Universität Bochum | Perfluorkohlenstoff-Nanoemulsionen mit Endozytose-verbessernder Oberfläche für die Genübertragung |
EP2547323B1 (de) | 2010-03-17 | 2016-01-27 | Novaliq GmbH | Pharmazeutische zusammensetzung zur behandlung erhöhten intraokulardrucks |
EP2444063A1 (de) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Flüssige pharmazeutische Zusammensetzungen zur Abgabe von Wirkstoffen |
EP2462921A1 (de) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Flüssige pharmazeutische Zusammensetzungen zur Behandlung einer Erkrankung der Hinterseite des Auges |
WO2012160180A2 (en) | 2011-05-25 | 2012-11-29 | Novaliq Gmbh | Pharmaceutical composition for administration to nails |
CN108283623A (zh) | 2011-05-25 | 2018-07-17 | 诺瓦利克有限责任公司 | 基于半氟化烷烃类的外用药物组合物 |
JP5902405B2 (ja) | 2011-06-15 | 2016-04-13 | 日本オーチス・エレベータ株式会社 | エレベータ装置 |
WO2013110621A1 (en) | 2012-01-23 | 2013-08-01 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes |
AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
KR101874219B1 (ko) | 2012-09-12 | 2018-07-03 | 노바리크 게엠베하 | 부분불소화 알칸의 혼합물을 포함하는 조성물 |
PL3024484T3 (pl) | 2013-07-23 | 2018-11-30 | Novaliq Gmbh | Stabilizowane kompozycje przeciwciał |
WO2016036674A1 (en) | 2014-09-02 | 2016-03-10 | Bhupinder Singh | Deuterated or a non-deuterated molecule and pharmaceutical formulations |
IL251588B1 (en) | 2014-10-08 | 2024-05-01 | Pacific Northwest Res Institute | Methods and preparations for increasing the potency of antifungal agents |
US20170087100A1 (en) | 2015-09-30 | 2017-03-30 | Novaliq Gmbh | Semifluorinated compounds and their compositions |
US11154513B2 (en) | 2015-09-30 | 2021-10-26 | Novaliq Gmbh | Semifluorinated compounds |
WO2017220625A1 (en) | 2016-06-23 | 2017-12-28 | Novaliq Gmbh | Topical administration method |
ES2969758T3 (es) | 2016-09-22 | 2024-05-22 | Novaliq Gmbh | Composiciones farmacéuticas para usar en la terapia de la blefaritis |
JP6869336B2 (ja) | 2016-09-23 | 2021-05-12 | ノバリック ゲーエムベーハー | シクロスポリンを含む眼科用組成物 |
KR102351816B1 (ko) | 2017-04-21 | 2022-01-17 | 노바리크 게엠베하 | 요오드 조성물 |
EP3621601A1 (de) | 2017-05-12 | 2020-03-18 | Novaliq GmbH | Pharmazeutische zusammensetzungen mit semifluorierten alkanen zur behandlung von beschwerden im zusammenhang mit kontaktlinsen |
CA3076776A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
JP7353292B2 (ja) | 2018-03-02 | 2023-09-29 | ノバリック ゲーエムベーハー | ネビボロールを含む医薬組成物 |
WO2019191119A1 (en) | 2018-03-28 | 2019-10-03 | Herbalife International Of America, Inc. | Acetylation of polysaccharides |
ES2950878T3 (es) | 2018-09-27 | 2023-10-16 | Dermaliq Therapeutics Inc | Formulación de protección solar de uso tópico |
CN112823020A (zh) | 2018-10-12 | 2021-05-18 | 诺瓦利克有限责任公司 | 用于治疗干眼病的眼用组合物 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3975512A (en) * | 1970-12-21 | 1976-08-17 | University Of Illinois Foundation | Non-toxic brominated perfluorocarbons radiopaque agents |
GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
US5284645A (en) * | 1987-08-05 | 1994-02-08 | Alliance Pharmaceutical Corp. | Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems |
US4987154A (en) * | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
FR2602774B1 (fr) * | 1986-07-29 | 1990-10-19 | Atta | Nouvelles molecules amphiphiles polyhydroxylees et perfluoroalkylees ayant des proprietes tensioactives |
FR2620445B1 (fr) * | 1987-09-16 | 1990-07-20 | Centre Nat Rech Scient | Nouveaux derives fluores d'acides amines, utilisables en particulier comme agents tensioactifs ou cotensioactifs et preparations a usage biomedical comprenant ces derives |
US5114703A (en) * | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
AU639008B2 (en) * | 1989-06-22 | 1993-07-15 | Alliance Pharmaceutical Corporation | Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
FR2665705B1 (fr) * | 1990-08-09 | 1993-07-30 | Atta | Nouveaux derives fluores amphiphiles a structure telomere, leur procede de preparation et leur utilisation dans des preparations a usage biomedical. |
US5292499A (en) * | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
US5230884A (en) * | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US5173298A (en) * | 1990-09-27 | 1992-12-22 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
US5496535A (en) * | 1991-04-12 | 1996-03-05 | Alliance Pharmaceutical Corp. | Fluorocarbon contrast media for use with MRI and radiographic imaging |
FR2679150A1 (fr) * | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
CA2151491A1 (en) * | 1992-12-24 | 1994-07-07 | Robert J. Kaufman | Fluorocarbon emulsions |
FR2700696B1 (fr) * | 1993-01-28 | 1995-04-07 | Atta | Dispersions, émulsions, microémulsions, gels et compositions à usage biomédical comprenant un composé organique fluoré iodé, utilisables notamment comme agent de contraste. |
FR2720943B1 (fr) * | 1994-06-09 | 1996-08-23 | Applic Transferts Technolo | Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples. |
-
1995
- 1995-06-07 US US08/482,176 patent/US5667809A/en not_active Expired - Fee Related
-
1996
- 1996-06-05 AU AU60494/96A patent/AU721759B2/en not_active Ceased
- 1996-06-05 DK DK96918172T patent/DK0831770T3/da active
- 1996-06-05 HU HU9900872A patent/HUP9900872A2/hu unknown
- 1996-06-05 KR KR1019970709068A patent/KR100454377B1/ko not_active IP Right Cessation
- 1996-06-05 PL PL96323829A patent/PL323829A1/xx unknown
- 1996-06-05 AT AT96918172T patent/ATE195415T1/de not_active IP Right Cessation
- 1996-06-05 JP JP9501487A patent/JPH11506783A/ja active Pending
- 1996-06-05 WO PCT/US1996/009081 patent/WO1996040053A1/en active IP Right Grant
- 1996-06-05 PT PT96918172T patent/PT831770E/pt unknown
- 1996-06-05 ES ES96918172T patent/ES2150674T3/es not_active Expired - Lifetime
- 1996-06-05 CN CN96195982A patent/CN1192135A/zh active Pending
- 1996-06-05 CA CA002222081A patent/CA2222081A1/en not_active Abandoned
- 1996-06-05 DE DE69609834T patent/DE69609834T2/de not_active Expired - Fee Related
- 1996-06-05 EP EP96918172A patent/EP0831770B1/de not_active Expired - Lifetime
- 1996-06-05 IL IL12224196A patent/IL122241A0/xx unknown
-
1997
- 1997-11-19 NO NO975320A patent/NO975320L/no not_active Application Discontinuation
-
2000
- 2000-10-23 GR GR20000402347T patent/GR3034657T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0831770B1 (de) | 2000-08-16 |
DE69609834T2 (de) | 2000-12-21 |
KR19990022587A (ko) | 1999-03-25 |
CN1192135A (zh) | 1998-09-02 |
NO975320D0 (no) | 1997-11-19 |
US5667809A (en) | 1997-09-16 |
PL323829A1 (en) | 1998-04-27 |
MX9709690A (es) | 1998-03-29 |
WO1996040053A1 (en) | 1996-12-19 |
HUP9900872A2 (hu) | 1999-08-30 |
GR3034657T3 (en) | 2001-01-31 |
IL122241A0 (en) | 1998-04-05 |
DK0831770T3 (da) | 2000-12-18 |
EP0831770A1 (de) | 1998-04-01 |
AU721759B2 (en) | 2000-07-13 |
DE69609834D1 (de) | 2000-09-21 |
PT831770E (pt) | 2000-11-30 |
KR100454377B1 (ko) | 2005-08-04 |
JPH11506783A (ja) | 1999-06-15 |
CA2222081A1 (en) | 1996-12-19 |
ES2150674T3 (es) | 2000-12-01 |
AU6049496A (en) | 1996-12-30 |
NO975320L (no) | 1998-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69609834D1 (de) | Kontinuierliche mikrodispersionen von fluorierten verbindungen zur verabreichung von pharmazeutischen stoffen | |
HUP0300836A2 (hu) | Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása | |
RU93058379A (ru) | Фармацевтическая композиция, содержащая определенную липидную систему, способ получения композиции и ее применение | |
HUP9702424A2 (hu) | Olvadékextrudált szilárd hatóanyag-készítmények | |
YU96602A (sh) | Postupak za spravljanje smeše | |
DE69318503D1 (de) | Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung | |
ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
HUP0302567A2 (hu) | Epotilon analógokat tartalmazó parenterális adagolási formák és eljárás az előállításukra | |
ES2177652T3 (es) | Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion. | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
HRP20040354B1 (en) | Novel cyclosporin analog microemulsion preconcentrates | |
KR880004811A (ko) | 산화에 안정한 약제 조성물 | |
DE69808463D1 (de) | Selbstemulgierende formulierung enthaltend saure lipophile verbindungen | |
KR960000247A (ko) | 사이클로스포린a 함유 조성물 및 그의 제조방법 | |
US5362745A (en) | Oral pharmaceutical compositions containing melatonin | |
CA2236641A1 (en) | Preparation of fagopyritols and uses therefor | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
SE9302295D0 (sv) | New pharmaceutical composition | |
HUP0004362A2 (hu) | Karbamazepint vagy származékait tartalmazó parenterális készítmények | |
NO942076L (no) | Farmasöytisk blanding | |
RU94032143A (ru) | Композиция, содержащая препарат коагуляционного фактора viii, способ ее получения и применение поверхностно-активного вещества в качестве стабилизатора | |
RU94030464A (ru) | Фармацевтическая композиция, способ ее получения, способ лечения заболеваний дыхательных путей, применение фармацевтической композиции | |
HUP9903369A2 (hu) | 8(9)-Dehidroösztradiol-származékok | |
KR940003559A (ko) | 산조인으로부터 산조인알칼로이드류를 추출하는 방법 및 이 추출된 산조인알칼로이드류를 주성분으로 함유하는 약학적 제제 | |
DK0971701T3 (da) | Fremgangsmåde til fjernelse af höjtkogende oplösningsmidler fra lægemiddelformuleringer ved vakuumtörring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |